BCAR4 has been investigated in various cancers, and its oncogenic role has been reported in breast cancer, colorectal cancer, and cervical cancer (Xing et al., 2014; Xing et al., 2015; Ouyang et al., 2017; Zou et al., 2018). Here, BCAR4 is linked to breast carcinoma.